1-Chloro-2-isopropylsulfanyl-3-nitro-benzene, 85.0%, 1g

5-Bromo-2-methoxy-4-methylpyrimidine, 95.0%, 5g

3-(4-Chloro-phenyl)-3-oxo-propionic acid methylester, 95.0%, 25g

2-Bromo-6-fluoro-4-(trifluoromethyl)quinoline, 97%, 250mg

2,4-Dibromobenzo[d]thiazole, 98%, 250mg

2-Hydrazino-5-(trifluoromethyl)pyridine, HCl, 95.0%, 250mg

4,4'-(Cyclododecane-1,1-diyl)diphenol, 97.0%, 250mg

5-Chloromethyl-2-(4-chlorophenyl)-1H-imidazole, 95.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece

Silica gel 60, 1 kg

3-Bromo-4-nitrotoluene, 95.0%, 250mg

6,7-DIHYDRO-5H-PYRROLO[1,2-B][1,2,4]TRIAZOLE, 95.0%, 500mg

4-(Ethoxycarbonyl)-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 2.5g